Trend-Following Backtester · Guide · backtest 한국어

equity · CN

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Class A backtest

10 trend-following strategies were compared on the full daily history of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Class A. 10 beat buy-and-hold CAGR; SMA 크로스오버 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 9.4%, MDD -22.6%).

Data 2020-07-22 ~ 2026-07-31daily bars 1,462 (6.0 years)Costs 0.5%Venue SSEMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR 1.4%, drawdown -77.6%).

Sharpe leader (same as main): SMA 크로스오버 — CAGR 26.6%, MDD -42.0%, Sharpe 0.78, 55% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 25.2%p higher than buy and hold, while drawdown improves by 35.6%p (CAGR 9.4%, MDD -22.6%, exposure 10%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
SMA 크로스오버
fast=52, slow=152
26.6%-42.0%0.780.634.1x655%
EMA 크로스오버
fast=35, slow=212
20.8%-42.0%0.670.493.1x351%
ROC 모멘텀
n=129, threshold=0.08
15.6%-39.8%0.580.392.4x5241%
Supertrend
period=23, mult=2.3
14.9%-46.7%0.560.322.3x5042%
Donchian 채널 돌파
entryN=8, exitN=75
14.2%-43.7%0.520.332.2x1979%
ADX / DI 방향성
period=48, threshold=11
12.5%-43.8%0.490.292.0x2157%
Keltner 채널 돌파
emaPeriod=12, atrPeriod=26, mult=2.4
9.4%-22.6%0.480.421.7x2010%
MACD
fast=16, slow=69, signal=8
6.9%-47.2%0.370.151.5x8446%
볼린저 밴드 돌파
n=53, k=3
6.1%-32.4%0.350.191.4x1422%
Parabolic SAR
step=0.02, maxStep=0.24
2.7%-49.9%0.260.051.2x12644%
Buy and hold1.4%-77.6%0.270.021.1x1100%
1x 2021 2022 2023 2024 2025 2026 SMA 크로스오버Buy and hold
SMA 크로스오버: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -19% -39% -58% -78% 2021 2022 2023 2024 2025 2026 Buy and holdSMA 크로스오버
SMA 크로스오버 maximum drawdown -42.0% (2026-04-03 → 2026-06-08), prior peak not yet recovered.

Rules of the top strategy

When the short average rises above the long average, it reads that as an uptrend starting.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next